Dublin Medtech start-up wins €2.7m in funding
Oncomark’s diagnostic tech helps breast cancer patients avoid unnecessary chemotherapy
Done deal:€2.7m funding
The clincher: “This award will enable us to accelerate the OncoMasTR test from the laboratory to the clinic, as well as creating employment opportunities.” - Des O’Leary, chief executive, OncoMark
Diagnostic technology that could help breast cancer patients avoid unnecessary post-operative chemotherapy has earned a Dublin start-up €2.7 million in funding.
Subscribe from just 1€
Choose the subscription that is right for you
For the first month
€19.99 Monthly ThereafterSubscribe today
For the first year
€199.99 annually thereafterSubscribe today
For the first 90 days
€55.00 quarterly ThereafterSubscribe today
These offers are not available for current subscribers. Offers and pricing are subject to change without notice.
Terms & Conditions Apply